Invesco NASDAQ Future Gen 200 ETF(QQQS)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$33.28
11/20/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for QQQS

11/20/2026: QQQS (1-star) is currently NOT-A-BUY. Pass it for now.

The Invesco NASDAQ Future Gen 200 ETF (QQQS) provides targeted exposure to 200 small-cap, innovation-focused companies listed on Nasdaq by screening for strong patent portfolios. Its main strengths include a cost-effective 0.20% expense ratio, a unique intellectual property selection strategy, and zero overlap with standard Nasdaq-100 holdings. It functions primarily as a satellite growth allocation designed to capture early-stage technological leaders. However, investors face notable risks, including high volatility, heavy healthcare sector concentration, limited liquidity, and sensitivity to interest rate fluctuations. The fund is best suited for aggressive growth investors willing to monitor small-cap market dynamics and macro conditions.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitIt targets small-cap companies with high growth potential and valuable patent portfolios.
Momentum investorStrong fit while signal remains positiveIt can capture sharp rallies during risk-on phases for small-cap innovation sectors.
Value investorWeak fitThe portfolio features many pre-earnings or speculative small-cap growth firms with negative P/E ratios.
Dividend/Income investorWeak fitThe fund focuses on capital appreciation and early-stage innovators rather than dividend distributions.
Low-risk investorWeak fitSmall-cap equities and heavy healthcare concentration introduce substantial volatility and drawdown risk.

Investor Profile

Ideal Investor Profile

Growth-oriented investors with a high risk tolerance seeking satellite exposure to small-cap patent-rich innovators.

Suitability

Best suited for long-term investors looking to complement large-cap tech portfolios with emerging small-cap innovators.

Risk Profile

Risk factorLevelWhy it matters
VolatilityHighSmall-cap growth stocks routinely experience sharp price swings.
Market riskHighBroader equity market downturns heavily penalize speculative risk assets.
ConcentrationHighThe fund heavily concentrates over half of its weight in the healthcare sector.
Tracking/expenseLowThe low 0.20% expense ratio minimizes structural performance drag.
LiquidityMedium / highLower average daily trading volume can result in wider execution spreads.
Business/sector qualityMedium / highMany constituents are early-stage firms relying on clinical trials or unproven commercialization.

Sector & Industry Intelligence

This fund is not assigned to one sector.

Risk Analysis

Volatility

QQQS demonstrates high historical volatility due to its small-cap growth focus and heavy healthcare concentration.

Market Risk

The fund carries substantial market risk, making it vulnerable to sharp drawdowns during broader risk-off market cycles.

What the ETF Owns

Exposure TypeExposureWeight (%)Retail Investor Read
SectorHealthcare52.09Provides majority exposure to small-cap biotechnology and medical device innovators.
SectorTechnology30.15Captures emerging software, hardware, and tech-enabled business models outside the tech giants.
SectorIndustrials6.78Offers exposure to specialized industrial engineering and manufacturing innovators.
SectorConsumer Cyclical5.39Includes consumer-focused growth businesses with high intellectual property metrics.
SectorOther Sectors (Communication, Defensive, Materials, Energy)5.59Represents residual allocations across communication services, consumer defensive, basic materials, and energy.

Price Behavior

Rolling Over
PRICE PATH

Rolling Over

The price momentum is slowing down and beginning to turn downward.

Smooth
PRICE STABILITY

Smooth

The stock has moved along a generally orderly path with only modest fluctuations.

Analysis of Past Performance

Type ETF
Historic Profit 34.37%
Avg. Invested days 55
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
ETF Returns Performance Upturn Returns Performance icon 5.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/20/2026
Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.